Pierre Sérusclat

Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea

Julio Rosenstock, Andreas L. Birkenfeld, Thalia Marie Blicher et al. · JAMA · 2019 · 398 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial

Bernard Zinman, Vanita R. Aroda, John B. Buse et al. · Diabetes Care · 2019 · 282 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial

Julio Rosenstock, Ronnie Aronson, George Grunberger et al. · Diabetes Care · 2016 · 268 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study

Matthieu Wargny, Louis Potier, Pierre Gourdy et al. · Diabetologia · 2021 · 168 citations · Full text

Medicine, Internal Medicine, Disease Surveillance +14